RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FUDA G
Collezione AOU Novara

Items : 6

Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995-2018): Results From the Piemonte and Valle d'Aosta Registry. in Neurology / Neurology. 2025 Apr 22;104(8):e213467. doi: 10.1212/WNL.0000000000213467. Epub 2025 Mar 24.

2025
AOU Città della Salute di Torino
AOU Novara

Mazzini L; De Marchi F; Salamone P; Fuda G; Callegaro S; Iazzolino B; Pascariu D; Minerva E; Pellegrino G; Zocco G; Di Pede F; Matteoni E; Cabras S; Palumbo F; Grassano M; Manera U; Canosa A; Tafaro S; Vasta R; De Mattei F; Moglia C; Calvo A; Chiò A;

The role of peripheral immunity in ALS: a population-based study. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2023 Sep;10(9):1623-1632. doi: 10.1002/acn3.51853. Epub 2023 Jul 22.

2023
AOU Città della Salute di Torino
AOU Novara

Calvo A; Moglia C; Mazzini L; Casale F; Fuda G; Salamone P; Canosa A; Vasta R; Palumbo F; Solero L; Bombaci A; Daviddi M; Matteoni E; De Marchi F; Cugnasco P; Chiò A; Manera U; Grassano M;

Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis. in Journal of neurology / J Neurol. 2023 Nov;270(11):5475-5482. doi: 10.1007/s00415-023-11888-8. Epub 2023 Jul 25.

2023
AOU Città della Salute di Torino
AOU Novara

Calvo A; Chiò A; Manera U; De Marchi F; Moglia C; Mazzini L; Canosa A; Palumbo F; Fuda G; Marchese G; De Marco G; Bombaci A; Grassano M; De Mattei F; Matteoni E; Di Pede F; Sgambetterra S; Cabras S; Callegaro S; Vasta R;

Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs. in Amyotrophic lateral sclerosis & frontotemporal degeneration / Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):108-115. doi: 10.1080/21678421.2021

2022
AOU Città della Salute di Torino
AOU Novara

Calvo A; Chiò A; Moglia C; Mazzini L; De Marchi F; Mattei A; Launaro N; Cugnasco P; Fuda G; Salamone P; Grassano M; Canosa A; Vasta R; Torrieri MC; Mora G; Manera U;

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. in JAMA neurology / JAMA Neurol. 2021 Oct 1;78(10):1236-1248. doi: 10.1001/jamaneurol.2021.2598.

2021
AOU Città della Salute di Torino
AOU Novara

Tremolizzo L; Trojsi F; Torriello A; Tranquilli S; Tedeschi G; Ticca A; Tanel R; Simonini C; Spataro R; Simone I; Sbaiz L; Sideri R; Santarelli M; Salivetto M; Salvi F; Sabatelli M; Salamone P; Riolo G; Riva N; Russo M; Ricci C; Pugliatti M; Quattrini A; Pozzi S; Petrelli C; Petrucci A; Passaniti C; Origone P; Murru MR; et alii...

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial). in BMJ open / BMJ Open. 2020 Mar 24;10(3):e034049. doi: 10.1136/bmjopen-2019-034049.

2020
AOU Città della Salute di Torino
AOU Novara

Calvo A; Moglia C; Simone IL; Mandrioli J; La Bella V; Mazzini L; Caponnetto C; Lunetta C; Marrali G; Casale F; Fuda G; Salamone P; Tarella C; Chio A;